All-on-Four Implants With Ultrasonic

Bone Atrophy, Alveolar Clinical Trial

— Nobelsinus  

Official title:

Ultrasonic Preparation of the Implant Site in the All-on-Four Technique With Trans-sinus Implants

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03357692
• Other study ID #: Nobelsinus
• Status: Withdrawn
• Phase: N/A
• Start date: October 31, 2017
• Est. completion date: February 15, 2020

Study information

• Verified date: September 2020
• Source: International Piezosurgery Academy
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The objective of this observational study is the radiographic evaluation of marginal bone remodeling after surgical implant insertion in an immediate loading all-on-four technique with trans-sinusal titanium implants, correlating the gingival thickness and the height of the implant prosthetic stump with the proportion of the abovementioned marginal bone remodeling.

Description:

The extent of marginal bone remodeling around the neck of dental implants has been used for many years as a criterion for defining its long-term success.

In fact, the etiology of this Marginal Bone Loss has not yet been well understood, although many theories have been proposed to explain it.

The influence of the thickness of the mucous membrane on marginal bone loss was discussed elsewhere which suggests a protective action for the underlying soft tissue that recreates a kind of "biological amplitude" around the implant. Some studies have suggested that a marginally oscillating bone loss between 1.5 and 2.0 mm provides the vertical space for proper restoration of the biological amplitude. Some authors. published a study that demonstrated that, in crestal systems with switching platforms, a vertical thickness of soft tissue greater than 2 mm is effective in preventing periimplant crestal bone loss. However, the severity of the sample examined precludes the possibility of making definitive conclusions.

Recently other authors have shown significant marginal bone loss around implants with lower prosthetic implants than those with higher prosthetic prostheses, without however measuring the thickness of soft tissues and evaluating their influence. In particular, the extent of bone loss was extremely limited when the height of the stump was equal to or greater than 2 mm. From a theoretical point of view, a prosthetic abutment of at least 2 mm high, calculated from the apical margin of the crown to the platform of the implant, should provide adequate space for restoring the biological amplitude.

It can therefore be hypothesized that these two factors (the vertical thickness of soft tissues and the height of the prosthetic stump) are the expression of the same principle: the restoration of the biological amplitude around the implant's neck. From a clinical point of view it will be useful to determine which of the two factors is most important in preventing and limiting periimplant bone loss.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: February 15, 2020
• Est. primary completion date: October 31, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 19 Months and older

Eligibility

Inclusion Criteria:

1. indications for implant insertion into the maxillary upper jaw, based on a careful diagnosis and treatment plan;

2. presence of a residual bone crest with a minimum surgical height of 4 mm at the maxillary sinus (bilaterally), and a thickness of at least 6 mm at the two distally programmed implant sites;

3. presence of a residual bone crest with a minimum surgical height of 10 mm at the anterior maxilla, and a thickness of at least 6 mm at the mesially programmed implant sites;

4. the bone crest should be healed (at least 6 months after the loss / extraction of the corresponding dental element);

5. no regenerated bone;

6. Plaque index below 25% and bleeding index less than 20%;

7. the buccal length of the adherent gingiva = 4 mm;

8. age of the patient> 18 years;

9. systemic condition of the compensated patient (American Society of Anesthesiologist score < 2);

8) Patients should be able to examine and understand the protocol of study; 9) subscribing to informed consent.

Exclusion Criteria:

1. not treated diabetes

2. cardiovascular disease

3. incapability of maintaining a good oral hygiene

Related Conditions & MeSH terms

• Alveolar Bone Loss
• Atrophy
• Bone Atrophy, Alveolar

Intervention

Procedure:
• all on four implant rehabilitation
implant insertion after piezoelectric site preparation for trans-sinusal implants

Locations

Country	Name	City	State
Italy	Piezosurgery Academy	Parma

Sponsors (1)

Lead Sponsor	Collaborator
International Piezosurgery Academy

Country where clinical trial is conducted

Italy, 

References & Publications (2)

Agliardi EL, Tetè S, Romeo D, Malchiodi L, Gherlone E. Immediate function of partial fixed rehabilitation with axial and tilted implants having intrasinus insertion. J Craniofac Surg. 2014 May;25(3):851-5. doi: 10.1097/SCS.0000000000000959. — View Citation

Maló P, Rangert B, Nobre M. "All-on-Four" immediate-function concept with Brånemark System implants for completely edentulous mandibles: a retrospective clinical study. Clin Implant Dent Relat Res. 2003;5 Suppl 1:2-9. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	survival rate	percentage of implants surviving in oral cavity	two years after surgery
Secondary	radiographic distance between crestal bone and implant platform	radiographically assessed	two years after surgery